Connect with us

Technology

BioArctic and Mesenkia enter oncology research collaboration

Published

on

STOCKHOLM, August 19, 2026 /PRNewswire/ — BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) and Mesenkia Therapeutics announced today that the companies have signed a research collaboration agreement to explore a novel antibody-based approach for glioblastoma, one of the most aggressive and treatment-resistant forms of brain cancer, where effective delivery of large molecules to the brain remains a major challenge.

The collaboration combines BioArctic’s proprietary BrainTransporter™ technology with an antibody, developed with Mesenkia’s KITAIbodies® platform. The antibody targets HVEM[1], a protein found on the surface of certain glioblastoma tumor cells, including tumor stem cells. By addressing these cells, which are thought to contribute to tumor recurrence and treatment resistance, the project aims to unlock new treatment possibilities for patients with a very high unmet medical need.

Under the agreement, BioArctic will be responsible for generating a novel drug candidate by combining its BrainTransporter technology with Mesenkia’s antibody. BioArctic and Mesenkia thereafter plan to perform preclinical studies to validate the concept and, based on the results of these studies, decide on next steps.

This research collaboration represents an important step in expanding BioArctic’s BrainTransporter pipeline into oncology and further validates the platform’s potential beyond neurodegenerative diseases. It also builds on BioArctic’s core expertise in development and delivery of pharmaceuticals to the brain.

“We are excited to broaden our research and take a first step into oncology through this collaboration,” said Gunilla Osswald, Chief Executive Officer of BioArctic. “Glioblastoma remains one of the most challenging cancers to treat, with limited therapeutic options and poor prognosis for those affected. By combining our BrainTransporter technology with Mesenkia’s innovative antibody approach, we aim to target key disease-driving mechanisms to develop new ways to treat this devastating disease.”

“This agreement marks an important step for Mesenkia and creates clear opportunities to explore a new treatment strategy for patients with glioblastoma together with BioArctic. The need for new treatments is substantial, particularly given the challenge of delivering medicines to tumor cells throughout the brain. By combining Mesenkia’s antibody expertise with BioArctic’s BrainTransporter technology, we can address one of the disease’s key barriers in a new way. We look forward to advancing the concept together with BioArctic, with the long-term goal of enabling better treatment options for patients and their loved ones,” said Moa Fransson, Chief Executive Officer of Mesenkia.

The information was released for public disclosure, through the agency of the contact person below, on August 19, 2026, at 11:15 am CET.

For further information, please contact: 
BioArctic
Oskar Bosson, Chief Investor Relations & Communications Officer
E-mail: oskar.bosson@bioarctic.com
Telephone: +46 704 107 180

Jenny Ljunggren, External Communications and Investor Relations Manager
E-mail: jenny.ljunggren@bioarctic.com
Telephone: +46 76 013 86 08

Mesenkia
Moa Fransson, CEO
E-mail: moa.fransson@mesenkia.com
Telephone: +46 072 211 71 61

About Mesenkia Therapeutics AB

Mesenkia is a pre-clinical company developing the next-generation biological drug candidates designed to treat the aggressive brain tumor glioblastoma. Mesenkia is founded on world leading science from Uppsala University and the University of Tokyo originating from decades of collaborations dedicated to finding the root cause for tumor pathogenesis. The company’s lead program targets glioblastoma, while their KITAIbodies® are designed to enable future therapeutics across multiple indications and modalities. Through strategic collaborations with pharmaceutical companies, Mesenkia aims to accelerate drug development and create value for patients worldwide.

About BioArctic AB
BioArctic AB (publ) is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. The company invented Leqembi® (lecanemab) – the world’s first drug proven to slow the progression of the disease and reduce cognitive impairment in early Alzheimer’s disease. Leqembi has been developed together with BioArctic’s partner Eisai, who are responsible for regulatory interactions and commercialization globally. In addition to Leqembi, BioArctic has a broad research portfolio with antibodies against Parkinson’s disease and ALS as well as additional projects against Alzheimer’s disease. Several of the projects utilize the company’s proprietary BrainTransporter™ technology, which has the potential to actively transport antibodies across the blood-brain barrier to enhance the efficacy of the treatment. BioArctic’s B share (BIOA B) is listed on Nasdaq Stockholm Large Cap. For further information, please visit www.bioarctic.com.

[1] Herpes virus entry mediator, a protein that is part of the tumor necrosis factor (TNF) receptor superfamily.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioarctic/r/bioarctic-and-mesenkia-enter-oncology-research-collaboration,c4385181

The following files are available for download:

https://mb.cision.com/Main/9978/4385181/4224986.pdf

BioArctic and Mesenkia enter oncology research collaboration

View original content:https://www.prnewswire.co.uk/news-releases/bioarctic-and-mesenkia-enter-oncology-research-collaboration-302855134.html

Continue Reading

Technology

MassMedia Earns Two Honors at 2026 PRSA Las Vegas Pinnacle Awards

Published

on

By

Award-winning campaigns for Sam & Ash Injury Law and Nocturno Cocktail Bar demonstrate the agency’s strategic approach to building brands, strengthening reputations and driving meaningful results

LAS VEGAS, Nov. 17, 2026 /PRNewswire/ — MassMedia, a strategic growth partner for ambitious brands ready to grow, scale and perform, earned two honors at the 2026 Public Relations Society of America (PRSA) Las Vegas Valley Chapter Pinnacle Awards, recognizing its work for Sam & Ash Injury Law and Nocturno Cocktail Bar.

Presented October 28 at Siena Golf Club in Las Vegas, the awards recognize excellence in public relations, communications strategy and execution across Southern Nevada. MassMedia received a Pinnacle Award in Community Relations for its Safe Teen Driving campaign on behalf of Sam & Ash Injury Law and an Award of Excellence in Reputation and Brand Management for its work with Nocturno Cocktail Bar.

“Great public relations starts with understanding the business, not simply the assignment,” said Paula Yakubik, founder and CEO of MassMedia. “Whether we’re helping a client build a stronger connection with its community or establish a reputation in a competitive market, our role is to look beyond the immediate brief, uncover opportunities and develop strategies that make a meaningful difference. These awards reflect the thinking, creativity and collaboration our team brings to our client partnerships every day.”

For Sam & Ash Injury Law, MassMedia developed a community relations campaign that connected the firm’s commitment to public safety with an issue affecting Nevada families: teen driving safety. The Safe Teen Driving campaign invited students ages 16 to 22 across Nevada to share what safe driving means to them through an essay competition and pledge initiative, with opportunities to receive scholarships and prizes. The program generated nearly 1,000 essays and safe-driving pledges, up from 400 in its inaugural year, and secured more than 50 earned media placements with a combined potential audience reach of 68.7 million. Beyond increasing awareness, the campaign created opportunities for meaningful engagement with young drivers and reinforced Sam & Ash Injury Law’s commitment to the communities it serves.

For Nocturno Cocktail Bar, MassMedia developed a sustained public relations and reputation-building strategy designed to establish the emerging Las Vegas Arts District destination within a highly competitive national cocktail industry. The program combined local, national and industry media relations, executive positioning, journalist experiences, strategic collaborations and industry award opportunities. The campaign generated more than 180 earned media placements and a combined potential audience reach of 1.38 billion. Nocturno also earned a James Beard Award nomination and four major industry recognitions, helping elevate its visibility among leading cocktail destinations nationwide.

Together, the award-winning programs reflect MassMedia’s approach to communications: understanding each client’s business objectives, identifying opportunities to build meaningful connections and developing strategies that extend beyond publicity to support broader brand and business goals.

Founded in Las Vegas nearly 30 years ago, MassMedia has expanded its capabilities and geographic reach while maintaining its commitment to working as an invested extension of its clients’ teams. Today, the agency brings together strategy, creative, media, public relations, social, events and performance expertise to help brands navigate challenges, uncover opportunities and grow.

About MassMedia
MassMedia is a strategic growth partner for ambitious brands ready to grow, scale and perform. Founded nearly 30 years ago as a Las Vegas public relations firm, MassMedia has grown into an integrated agency of more than 35 people spanning strategy, creative, media, PR, social, events and performance. With offices in Las Vegas, Phoenix/Scottsdale and Orange County and media relationships in more than 100 markets, the agency works as an extension of its clients’ teams for brands including McDonald’s, Southwest Gas, Circus Circus Las Vegas and MAC.BID, with many partnerships lasting more than a decade. Learn more at massmediacc.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/massmedia-earns-two-honors-at-2026-prsa-las-vegas-pinnacle-awards-302942831.html

SOURCE Mass Media

Continue Reading

Technology

InPHRED Wins Best Technology Award at 2026 IEEE Photonics Conference Start-Up Competition

Published

on

By

Industry recognition highlights InPHRED’s nanoporous InP mirror technology and its potential to enable manufacturable 1310 nm VCSELs for AI optical interconnects

BOSTON, Nov. 18, 2026 /PRNewswire/ — InPHRED, Inc., a developer of advanced semiconductor light sources based on its proprietary nanoporous photonics platform, today announced that it received the Best Technology award at the inaugural Start-Up Competition held during the 2026 IEEE Photonics Conference (IPC). The competition was organized by the IEEE Photonics Society’s Industry Engagement Committee and LightCounting.

Selected from seven finalists, InPHRED was recognized for its approach to a longstanding challenge in long-wavelength vertical-cavity surface-emitting lasers (VCSELs): creating high-reflectivity mirrors directly on indium phosphide (InP) using a wafer-scale, foundry-compatible process. The technology is designed to combine the manufacturing advantages of VCSELs with the single-mode fiber compatibility of 1310 nm optical links.

“This award recognizes the technical foundation of what we are building: a practical route to manufacturing long-wavelength VCSELs on InP,” said Dr. Jacob Tarn, Chief Executive Officer and Chairman of InPHRED. “By addressing the mirror challenge within a conventional semiconductor manufacturing framework, we believe our platform can open new opportunities for scalable, energy-efficient optical connectivity.”

A manufacturable approach to long-wavelength VCSELs

Conventional VCSELs have benefited from highly efficient semiconductor mirrors available on gallium arsenide (GaAs). Extending that manufacturing model to the 1310 nm wavelength band has been difficult because InP-based material systems lack a comparably straightforward, high-index-contrast mirror structure.

InPHRED’s patented nanoporous distributed Bragg reflector (DBR) technology addresses this constraint through selective electrochemical processing of epitaxial InP layers. The resulting refractive-index contrast enables highly reflective mirrors while preserving compatibility with established compound-semiconductor wafer-processing methods. The company is applying this platform across commercial sensing and optical interconnect applications.

Enabling optical connectivity for AI infrastructure

As AI computing systems scale, optical interconnect architectures are evolving to address bandwidth density, power consumption and integration complexity. InPHRED is developing 1310 nm InP VCSEL technology for single-mode optical links, including integration approaches compatible with silicon photonics and next-generation optical engines.

“The recognition from the IPC industry judging panel reinforces the relevance of our approach to the optical interconnect ecosystem,” said Dr. Rebecca Levonian, Chief Business Officer of InPHRED, who presented at the competition. “We look forward to working with photonic integrated circuit developers, optical engine and module manufacturers, and system partners to evaluate how InP VCSELs can support future AI infrastructure.”

InPHRED congratulates fellow competition finalists and thanks the IEEE Photonics Society, LightCounting and the industry judging panel for supporting emerging photonics technologies.

About InPHRED

Founded in 2023, InPHRED is a semiconductor photonics company developing short-wave infrared VCSELs and visible resonant-cavity light sources based on a patented nanoporous semiconductor platform originating from research at Yale University. Its technology is designed for foundry-compatible manufacturing and applications spanning sensing, digital health and next-generation optical interconnects. Learn more at www.inphred.com.

Media Contact
InPHRED, Inc. | info@inphred.com | www.inphred.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/inphred-wins-best-technology-award-at-2026-ieee-photonics-conference-start-up-competition-302942856.html

SOURCE INPHRED

Continue Reading

Technology

Isotec Security, Inc. Expands K-12 School Safety Support with New CEIA-Certified OPENGATE Trainers

Published

on

By

Longtime CEIA partner strengthens access to specialized weapons detection training, helping schools streamline security procedures and create safer learning environments.

WESTMINSTER, Colo., Nov. 17, 2026 /PRNewswire/ — Isotec Security, Inc., a provider of advanced security screening and integrated weapons detection solutions, is proud to announce that team members Aaron Rushton and Louis Romersheuser have earned CEIA certifications to provide OPENGATE weapons detection system training for K-12 schools.

Isotec Security, Inc. expands access to specialized CEIA-certified OPENGATE training for K-12 schools.

As more school districts adopt weapons detection technology, ensuring staff can confidently operate these systems is essential. Coordinating training across busy academic schedules, multiple campuses, and varying security requirements can be challenging. With two newly certified trainers, Isotec can provide more accessible, manufacturer-certified instruction tailored to individual school environments.

“School safety is about more than installing the right equipment. It’s about making sure the people responsible for protecting students feel confident and prepared to use it,” said David Barnes, CEO of Isotec Security, Inc. “We’re incredibly excited that Aaron and Louis have earned these certifications because it gives us another opportunity to support the teams who work hard to keep our schools safe. Having great security systems with undertrained staff presents huge risks. When security is efficient and well understood, it becomes a natural part of the school day, allowing students to focus on learning and educators to focus on teaching.”

CEIA’s OPENGATE is a portable, high-throughput weapons detection system designed to identify metallic weapons while allowing students and visitors to pass through screening checkpoints without complete divestment. Every school campus presents unique security challenges, and the flexible design enables schools to adapt screening locations as security needs change.

CEIA-certified training is mandatory for most schools as it ensures staff personalize and fully understand the differences between a weapons and metal detector, the various detection settings, equipment placement, screening staff roles and responsibilities, alarm response procedures, and traffic management to best fit their needs. By addressing each campus’s operational needs, Isotec helps schools establish consistent screening procedures while maintaining efficient, welcoming learning environments.

“Isotec has been a trusted partner in bringing CEIA technology to organizations that take safety seriously, and their continued investment in education and training demonstrates their commitment to doing the job right,” said Tom McDermott, K-12 Safety & Security Coach & Market Manager at CEIA USA. “Aaron and Louis earning these certifications is a tremendous benefit to the school districts and communities we help protect.”

Isotec Security has been proudly partnered with CEIA for nearly three decades, bringing advanced metal and weapons detection technology to safety-minded organizations nationwide. With these expanded training capabilities, Isotec looks forward to helping more school districts implement effective weapons screening procedures that support campus safety while minimizing disruptions to the educational experience.

To learn more about OPENGATE weapons detection systems or K-12 training opportunities, visit www.isotecsecurity.com.

About Isotec Security, Inc.

Founded in 1998, Isotec Security pioneered the development of Safety Entrances and has become a trusted leader in layered security and access control. Its technologies protect some of the most secure facilities on the planet, including government agencies, critical infrastructure, and commercial institutions. With a focus on seamless integration, reliability, and user-friendly operation, Isotec helps organizations prevent threats, protect people and assets, and provide peace of mind in an unpredictable world.

About CEIA USA

CEIA USA is a global leader in advanced security screening technology, providing innovative solutions for threat detection across aviation, critical infrastructure, public venues, education and government sectors. With a commitment to combining uncompromising security with operational efficiency and user experience, CEIA USA develops cutting-edge technology that addresses the growing challenges faced by security professionals worldwide. For more information, go to ceia-usa.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/isotec-security-inc-expands-k-12-school-safety-support-with-new-ceia-certified-opengate-trainers-302942858.html

SOURCE Isotec Security, Inc

Continue Reading

Trending